FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2055654248> ?p ?o ?g. }

• W2055654248 endingPage "1195" @default.
• W2055654248 startingPage "1188" @default.
• W2055654248 abstract "The annual incidence of non-Hodgkin lymphoma (NHL) has increased over the past two decades in all age groups, including the elderly. Establishing guidelines for proper care for this segment of the population requires further information.Between January 1993 and April 2002, 187 consecutive patients with NHL who were age 70 years or older were examined as part of the current study. Potential factors implicated in prognosis were analyzed for indolent lymphoma group and aggressive lymphoma group separately.The median patient age was 75 years (range, 70-90 years), and 83% of the patients examined were male. Fifty-two patients (28%) had indolent lymphoma, and 135 patients (72%) had aggressive lymphoma. The complete remission rate was 33.3% for patients with indolent lymphoma and 35.9% for patients with aggressive lymphoma. Median overall survival was 41.5 months and 23.7 months for the indolent and aggressive lymphoma groups, respectively. The 1-year and 5-year survival rates were 76% and 32%, respectively, for patients with indolent lymphoma and 62% and 29%, respectively, for patients with aggressive lymphoma. Among patients with indolent lymphoma, poor prognosis was correlated with poor performance status (P = 0.0107), advanced disease stage (P = 0.0222), initial bone marrow involvement (P = 0.0069), and age greater than 80 years (P = 0.0486); however, none of these variables remained statistically significant after multivariate Cox regression. Among patients with aggressive lymphoma, the only prognostic factors that remained after multivariate analysis were performance status (P = 0.018) and age greater than 80 years (P = 0.029). For patients who received at least 2 courses of systemic chemotherapy, an anthracycline-containing regimen did not affect the survival rate in either the indolent lymphoma group (P = 0.81) or the aggressive lymphoma group (P = 0.34). After stratification, it was found that patients with aggressive lymphoma who were in the high-intermediate-risk group (as determined by International Prognostic Index [IPI] score) benefited most from the anthracycline-containing regimen (P = 0.0148).Performance status was identified as the major prognostic determinant for elderly patients with aggressive NHL. In addition, it was found that an anthracycline-containing treatment regimen may be especially beneficial for patients in the high-intermediate-risk category as determined by IPI score." @default.
• W2055654248 created "2016-06-24" @default.
• W2055654248 creator A5004548381 @default.
• W2055654248 creator A5018916934 @default.
• W2055654248 creator A5023426618 @default.
• W2055654248 creator A5026192090 @default.
• W2055654248 creator A5042834618 @default.
• W2055654248 creator A5042931408 @default.
• W2055654248 creator A5064526474 @default.
• W2055654248 creator A5070238855 @default.
• W2055654248 creator A5089081230 @default.
• W2055654248 date "2003-09-08" @default.
• W2055654248 modified "2023-10-16" @default.
• W2055654248 title "Non-Hodgkin lymphoma in elderly patients" @default.
• W2055654248 cites W1811037815 @default.
• W2055654248 cites W1905145727 @default.
• W2055654248 cites W1911079819 @default.
• W2055654248 cites W1924320258 @default.
• W2055654248 cites W1948967656 @default.
• W2055654248 cites W1965197112 @default.
• W2055654248 cites W1999725092 @default.
• W2055654248 cites W2000379682 @default.
• W2055654248 cites W2035086391 @default.
• W2055654248 cites W2036711551 @default.
• W2055654248 cites W2058015212 @default.
• W2055654248 cites W2070336578 @default.
• W2055654248 cites W2070750498 @default.
• W2055654248 cites W2074735426 @default.
• W2055654248 cites W2085733305 @default.
• W2055654248 cites W2104435282 @default.
• W2055654248 cites W2107202569 @default.
• W2055654248 cites W2126001705 @default.
• W2055654248 cites W2144843163 @default.
• W2055654248 cites W2168926834 @default.
• W2055654248 cites W2174428418 @default.
• W2055654248 cites W2220103122 @default.
• W2055654248 cites W2248522132 @default.
• W2055654248 cites W2318772898 @default.
• W2055654248 cites W2334996101 @default.
• W2055654248 cites W2426460202 @default.
• W2055654248 cites W4205736005 @default.
• W2055654248 cites W4238329799 @default.
• W2055654248 doi "https://doi.org/10.1002/cncr.11609" @default.
• W2055654248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12973842" @default.
• W2055654248 hasPublicationYear "2003" @default.
• W2055654248 type Work @default.
• W2055654248 sameAs 2055654248 @default.
• W2055654248 citedByCount "6" @default.
• W2055654248 countsByYear W20556542482017 @default.
• W2055654248 countsByYear W20556542482018 @default.
• W2055654248 countsByYear W20556542482020 @default.
• W2055654248 crossrefType "journal-article" @default.
• W2055654248 hasAuthorship W2055654248A5004548381 @default.
• W2055654248 hasAuthorship W2055654248A5018916934 @default.
• W2055654248 hasAuthorship W2055654248A5023426618 @default.
• W2055654248 hasAuthorship W2055654248A5026192090 @default.
• W2055654248 hasAuthorship W2055654248A5042834618 @default.
• W2055654248 hasAuthorship W2055654248A5042931408 @default.
• W2055654248 hasAuthorship W2055654248A5064526474 @default.
• W2055654248 hasAuthorship W2055654248A5070238855 @default.
• W2055654248 hasAuthorship W2055654248A5089081230 @default.
• W2055654248 hasBestOaLocation W20556542481 @default.
• W2055654248 hasConcept C120665830 @default.
• W2055654248 hasConcept C121332964 @default.
• W2055654248 hasConcept C126322002 @default.
• W2055654248 hasConcept C146357865 @default.
• W2055654248 hasConcept C151730666 @default.
• W2055654248 hasConcept C2779338263 @default.
• W2055654248 hasConcept C2780653079 @default.
• W2055654248 hasConcept C2781214270 @default.
• W2055654248 hasConcept C2908647359 @default.
• W2055654248 hasConcept C50382708 @default.
• W2055654248 hasConcept C61511704 @default.
• W2055654248 hasConcept C71924100 @default.
• W2055654248 hasConcept C86803240 @default.
• W2055654248 hasConcept C90924648 @default.
• W2055654248 hasConcept C99454951 @default.
• W2055654248 hasConceptScore W2055654248C120665830 @default.
• W2055654248 hasConceptScore W2055654248C121332964 @default.
• W2055654248 hasConceptScore W2055654248C126322002 @default.
• W2055654248 hasConceptScore W2055654248C146357865 @default.
• W2055654248 hasConceptScore W2055654248C151730666 @default.
• W2055654248 hasConceptScore W2055654248C2779338263 @default.
• W2055654248 hasConceptScore W2055654248C2780653079 @default.
• W2055654248 hasConceptScore W2055654248C2781214270 @default.
• W2055654248 hasConceptScore W2055654248C2908647359 @default.
• W2055654248 hasConceptScore W2055654248C50382708 @default.
• W2055654248 hasConceptScore W2055654248C61511704 @default.
• W2055654248 hasConceptScore W2055654248C71924100 @default.
• W2055654248 hasConceptScore W2055654248C86803240 @default.
• W2055654248 hasConceptScore W2055654248C90924648 @default.
• W2055654248 hasConceptScore W2055654248C99454951 @default.
• W2055654248 hasIssue "6" @default.
• W2055654248 hasLocation W20556542481 @default.
• W2055654248 hasLocation W20556542482 @default.
• W2055654248 hasOpenAccess W2055654248 @default.
• W2055654248 hasPrimaryLocation W20556542481 @default.
• W2055654248 hasRelatedWork W1580426574 @default.

• next